Foot Diseases — Baropodometric Assessment of the Podiatric Profile of Nursing Students in Clinical Settings
Citation(s)
Abledu JK, Offei EB Musculoskeletal disorders among first-year Ghanaian students in a nursing college. Afr Health Sci. 2015 Jun;15(2):444-9. doi: 10.4314/ahs.v15i2.18.
Chiwaridzo M, Makotore V, Dambi JM, Munambah N, Mhlanga M Work-related musculoskeletal disorders among registered general nurses: a case of a large central hospital in Harare, Zimbabwe. BMC Res Notes. 2018 May 18;11(1):315. doi: 10.1186/s13104-018-3412-8.
Stolt M, Katajisto J, Peltonen J, Suhonen R, Leino-Kilpi H Development and testing of a new electronic foot health promotion programme on nurses' foot self-care. BMC Nurs. 2020 Apr 19;19:29. doi: 10.1186/s12912-020-00423-z. eCollection 2020.
Stolt M, Miikkola M, Suhonen R, Leino-Kilpi H Nurses' Perceptions of Their Foot Health: Implications for Occupational Health Care. Workplace Health Saf. 2018 Mar;66(3):136-143. doi: 10.1177/2165079917727011. Epub 2017 Aug 31.
Yan P, Li F, Zhang L, Yang Y, Huang A, Wang Y, Yao H Prevalence of Work-Related Musculoskeletal Disorders in the Nurses Working in Hospitals of Xinjiang Uygur Autonomous Region. Pain Res Manag. 2017;2017:5757108. doi: 10.1155/2017/5757108. Epub 2017 Jul 13.
Baropodometric Assessment of the Podiatric Profile of Nursing Students in Clinical Settings
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
